Home > Press > Raymor Signs Titanium Powder Supply Agreement With New European Client for a Minimum of $1,000,000/Yr for 2008 & 2009
Abstract:
Raymor Industries Inc. (TSX VENTURE:RAR), a leading developer and producer of single-walled carbon nanotubes, nanomaterials and advanced materials, announces that its wholly-owned subsidiary, AP&C Advanced Powders and Coatings has signed a titanium powder supply agreement with a new international European-based client, which will generate sales of a minimum of $1,000,000 per year for 2008 and 2009. This client, whose identity is protected by a confidentiality agreement in place, has developed applications for AP&C powders primarily to service the biomedical and aerospace sectors. Raymor expects its long-term relationship with this client to grow in the coming years. Orders received to date by AP&C which are deliverable in 2008 amount to $3.5 million, as compared to $2.5 million for all of 2007. With qualifications underway with new clients, more orders are expected before the end of this year. Also, with the 2nd powder production unit in operation, coupled with its process optimization work, Raymor has now more than doubled its production capacity to meet the growing needs of this new client as well as additional demand from other clients.
Stephane Robert, President and CEO of Raymor Industries, had the following to say:
"Since AP&C signed its first large volume contract with a major US orthopedic implant company, AP&C has been receiving many interest for its unique, high-quality titanium powders. This new international, European-based client is a very positive addition to our list of clients because they develop different applications for international clients in the aerospace and biomedical industry with AP&C powders. The potential for increased business volume from this new client is excellent."
AP&C's metallic powders, including CP Ti, Ti-6Al-4V, and Nitinol, are produced using the patented Plasma Wire Atomization (PWA) Process. This globally unique process produces a highly pure metallic powder with an exceptional sphericity. These two properties allow AP&C's metallic powders to offer the best performance for aerospace, aeronautical, biomedical and defense applications.
Also, as mentioned in our September 2nd, 2008 press release, Raymor is currently negotiating financing alternatives with different lenders and investors in order to secure the funds required for its ongoing operations including factoring arrangements. With regards to these financing alternatives, a private placement of between $1 million to $2 million at the best market conditions available is currently being negotiated. As well, factoring agreement facilities based on raw materials, inventory, and purchase orders is also presently being negotiated.
####
About Raymor Industries Inc.
RAYMOR INDUSTRIES INC. (TSX VENTURE:RAR) has as its mission to become a leading developer of high technology for the production of single-walled carbon nanotubes, nanomaterials and other advanced materials for high value-added applications. Raymor Industries operates three wholly-owned, industrial subsidiaries, Raymor Nanotech, Raymor Aerospace and AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four divisions: (1) nanotechnology products, including nano-powders, nano-coatings, and single-walled carbon nanotubes (C-SWNT) for "the applications of tomorrow"; (2) thermal spray coatings, which largely targets military, aeronautical, aerospace, specialized industrial, and mining applications; (3) spherical metallic powders, primarily used for biomedical and aerospace applications; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to more than 20 patents throughout the world, with other patents pending.
ON BEHALF OF THE BOARD OF DIRECTORS
Stephane Robert, President.
(VERSION FRANCAISE SERA DISPONIBLE SUR LE SITE WEB DE RAYMOR)
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
For more information, please click here
Contacts:
Investor Relations:
450-434-1004 ext. 444
1-877-734-1004
450-434-1300 (FAX)
or
Media Relations:
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Aerospace/Space
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Under pressure - space exploration in our time: Advancing space exploration through diverse collaborations and ethical policies February 16th, 2024
Bridging light and electrons January 12th, 2024
New-Contracts/Sales/Customers
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020
GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||